Design Therapeutics, Inc. (DSGN)
NASDAQ · Healthcare
Design Therapeutics, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2020 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 0 | 0 | 226,000 |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -79.5M | -62.4M | -8.3M |
| EBITDA | — | — | — |
| Net Income | -69.8M | -49.6M | -8.3M |
| Per Share Data | |||
| EPS (diluted) | $-1.22 | $-0.88 | — |
| Shares Outstanding (dil.) | 57M | 57M | 16M |
Design Therapeutics, Inc. Income Statement — FAQ
Design Therapeutics, Inc. (DSGN) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DSGN's income statement history?
The chart and table above show Design Therapeutics, Inc.'s income statement by year and by quarter, including the growth rate.